Searched for
PE FUND CARLYLE GROUP
SoftBank Vision Fund CFO Navneet Govil exits after a decade as AI bets take centre stageNavneet Govil, the chief financial officer of SoftBank's Vision Fund, is departing after a decade. His exit comes as the investment giant, ...
Nifty’s hidden discount sale: 54% of top Indian stocks are cheaper now than in 2023. Is it time to buy?Over half of India's top Nifty50 stocks are now trading at lower forward P/E multiples than in 2023, indicating a significant valuation cor...
Debt mutual funds see outflow of Rs 96,948 crore in May after April surge. What triggered the reversal?
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
AI Wants to Answer Your Phone Now: Equal AI’s $30 Million Bet on the Future of Call Screening in IndiaIndian startup Equal AI has raised $30 million to expand its AI-powered call screening platform that answers and filters calls on users' be...
VCs turn the screws; Ex-Paisabazaar CEO’s new betHappy Friday! Investors are rewriting the rules of engagement with founders after governance blowups. This and more in today’s ETtech Morni...
Keshav Reddy's Equal AI raises $30 million in round led by Prosus, Tomales Bay CapitalThe round also saw participation from Think Investments, Valiant Fund, PhonePe founder Sameer Nigam, and Zubin Bharti Mittal, among others....
C’mon SEBI, step out & save: The market regulator should fix flawed IPO rules to stem inflated valuations, and capital flightCoca-Cola may list on Indian stock exchanges next year, a significant shift after 50 years. This move could expose inflated valuations due ...
Vodafone Idea shares jump 4%; KM Birla says telco navigated through one of its toughest challenges in historyVodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promot...
VC contract terms get tougher on founder shares after governance lapsesVenture capital firms are tightening founder contracts, with nearly 76% of Indian startups now allowing the forfeiture of vested shares for...
World's richest and their sleep habits: How many hours do Elon Musk, Jeff Bezos and Mark Zuckerberg sleep each day?Contrary to popular belief, top entrepreneurs like Jeff Bezos, Elon Musk, and Mark Zuckerberg emphasize the importance of sleep for product...
Proposed commission caps may drive consolidation in insurance distribution: Acko CEOAcko founder Varun Dua anticipates regulatory changes to insurance distributor commissions will drive consolidation and professionalization...
Carlyle seeks banks for India IPO of healthcare RCM providerCarlyle has sought investment bank pitches for a potential India IPO of its healthcare revenue cycle management platform created through th...
PhonePe launches AI-powered SmartPages to help merchants go online in 10 minutesPhonePe has introduced SmartPages, an AI tool for merchants. This innovation allows businesses to build payment-ready webpages in under ten...
ET Explainer: Why largecaps are gaining appeal as Nifty consolidatesWith Nifty 50 valuations at long-term averages, wealth managers suggest allocating to large-cap stocks. These companies offer stability and...
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 croreViyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...
Attractive valuations, improving earnings: Why fund managers are now raising their exposure to small-cap stocksMidcap stocks have dominated performance for a decade, but a shift towards small caps is emerging. Flexi-cap funds are increasing small-cap...